Icon Group appoints Aldo Rolfo as CEO for Europe to drive expansion

Icon Writers / 19 Mar, 2025

Icon Group has announced the appointment of Aldo Rolfo as Chief Executive Officer for Europe, reinforcing our commitment to delivering world-class healthcare across the region.

Aldo has played a pivotal role in shaping Icon’s growth strategy in the UK, leveraging his extensive experience and deep industry connections. During his tenure as Executive Manager – Strategic Growth, he has led key partnerships that have strengthened Icon’s presence globally, including collaborations with the Australian Department of Health, the UK’s National Health Service (NHS), and the acquisition of Cancer Centre London (CCL) through Icon’s strategic partnership with Nuffield Health.

Regional leadership

In his new role as CEO, Aldo will focus on advancing Icon’s integrated cancer care model, exploring new opportunities in oncology, pharmacy, compounding, and research across the UK and Europe. He will work closely with Ian Muir, CEO of Pharmaxo Group, to align the company’s capabilities in cancer treatment and pharmaceutical services, ensuring a seamless approach to healthcare delivery in the region.

Icon Group CEO, Mark Middleton said this appointment marks a natural next step in Icon’s strategic growth in the region.

“Aldo’s leadership and strategic vision make him the ideal choice to drive our growth and impact in Europe,” Mark said.

“His proven expertise in forging partnerships and navigating the local healthcare landscape will be instrumental as we continue to expand access to high-quality cancer treatments and integrated healthcare.”

 

Aldo is supported by a strong regional leadership team. Together, they will work towards enhancing patient access, improving outcomes, setting new benchmarks in cancer care and introducing Icon’s comprehensive healthcare model.

Icon’s expansion into the UK continues to deliver on our mission to deliver the best possible care to patients worldwide. Aldo’s appointment positions Icon for the next phase of innovation and growth in Europe.

View all News

Search

Contact us